Regulation of cyclooxygenase-2 expression by nitric oxide in cells

Antioxidants and Redox Signaling

Volumn 3, Issue 2, 2001, Pages 231-248

  Pérez Sala, Dolores ^a   Lamas, Santiago ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTANOID; TRANSCRIPTION FACTOR;

ANTIOXIDANT ACTIVITY; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; INFLAMMATORY DISEASE; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; TISSUE DISTRIBUTION;

MAMMALIA;

EID: 0035000952     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601300185197     Document Type: Review

References (141)

1. Akarasereenont P, Mitchell JA, Appleton I, Thiemermann C, and Vane JR. Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells. Br J Pharmacol 113: 1522-1528, 1994.
2. Allport VC, Slater DM, Newton R, and Bennett PR. NF-κB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod 6: 561-565, 2000.
3. Appleby SB, Ristimaki A, Neilson K, Narko K, and Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J 302: 723-727, 1994.
4. Baeuerle PA. Pro-inflammatory signaling: last pieces in the NF-κB puzzle? Curr Biol 8: R19-R22, 1998.
5. Baeuerle PA, and Baichwal VR. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 65: 111-37, 1997.
6. Baker CS, Hall RJ, Evans TJ, Pomerance A, Maclouf J, Creminon C, Yacoub MH, and Polak JM. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol 19: 646-655, 1999.
7. Beckman JS, and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C1437, 1996.
8. Bellamy TC, Wood J, Goodwin DA, and Garthwaite J. Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc Natl Acad Sci U S A 97: 2928-2933, 2000.
9. Belsham DD, Wetsel WC, and Mellon PL. NMDA and nitric oxide act through the cGMP signal transduction pathway to repress hypothalamic gonadotropin-releasing hormone gene expression. EMBO J 15: 538-547, 1996.
10. Belton O, Byrne D, Kearney D, Leahy A, and Fitzgerald DJ. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 102: 840-845, 2000.
11. Berendji D, Kolb-Bachofen V, Zipfel PF, Skerka C, Calberg C, and Kroncke KD. Zinc finger transcription factors as molecular targets for nitric oxide-mediated immunosuppression: inhibition of IL-2 gene expression in murine lymphocytes. Mol Med 5: 721-730, 1999.
12. Browning DD, McShane MP, Marty C, and Ye RD. Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase. J Biol Chem 275: 2811-2816, 2000.
13. Callsen D, Pfeilschifter J, and Brune B. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition. J Immunol 161: 4852-4858, 1998.
14. Castrillo A, Diaz-Guerra MJ, Hortelano S, Martin-Sanz P, and Bosca L. Inhibition of IκB kinase and IκB phosphorylation by 15-deoxy-delta(12,14)-prostaglandin J(2) in activated murine macrophages. Mol Cell Biol 20: 1692-1698, 2000.
15. Chen C, Chen YH, and Lin WW. Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 97: 124-129, 1999.
16. Chen CC, Chiu KT, Sun YT, and Chen WC. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. Involvement of cyclooxygenase-2. J Biol Chem 274: 31559-31564, 1999.
17. Chen CC, Sun YT, Chen JJ, and Chiu KT. TNF-α-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma2, protein kinase C-alpha, tyrosine kinase, NF-κB-inducing kinase, and I-κB kinase 1/2 pathway. J Immunol 165: 2719-2728, 2000.
18. Collard CD, Agah A, Reenstra W, Buras J, and Stahl GL. Endothelial nuclear factor-κB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues. Arterioscler Thromb Vasc Biol 19: 2623-2629, 1999.
19. Cooper CE. Nitric oxide and iron proteins. Biochim Biophys Acta 1411: 290-309, 1999.
20. Corbett JA, Kwon G, Marino MH, Rodi CP, Sullivan PM, Turk J, and McDaniel ML. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol 270: C1581-C1587, 1996.
21. Díaz-Cazorla M, Pérez-Sala D, and Lamas S. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells. J Am Soc Nephrol 10: 943-952, 1999.
22. Dumont I, Peri KG, Hardy P, Hou X, Martinez-Bermudez AK, Molotchnikoff S, Varma DR, and Chemtob S. PGE2, via EP3 receptors, regulates brain nitric oxide synthase in the perinatal period. Am J Physiol 275: R1812-R1821, 1998.
23. Dumont I, Hardy P, Peri KG, Hou X, Molotchnikoff S, Varma DR, and Chemtob S. Regulation of endothelial nitric oxide synthase by PGD(2) in the developing choroid. Am J Physiol 278: H60-H66, 2000.
24. Eigler A, Moeller J, and Endres S. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J Immunol 154: 4048-4054, 1995.
25. Filippov G, Bloch DB, and Bloch KD. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 100: 942-948, 1997.
26. Fowler AA, Fisher BJ, Sweeney LB, Wallace TJ, Natarajan R, Ghosh SS, and Ghosh S. Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-κB binding to DNA: effects on endothelial functions. Biochem Cell Biol 77: 201-208, 1999.
27. Frank S, Kampfer H, Podda M, Kaufmann R, and Pfeilschifter J. Identification of copper/zinc superoxide dismutase as a nitric oxide-regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation. Biochem J 346: 719-728, 2000.
28. Galea E, and Feinstein DL. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J 13: 2125-2137, 1999.
29. Ghosh S, May MJ, and Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998.
30. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, and Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698-701, 1999.
31. Guan Z, Baier LD, and Morrison AR. p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1β. J Biol Chem 272: 8083-8089, 1997.
32. 2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 273: 28670-28676, 1998.
33. Guastadisegni C, Minghetti L, Nicolini A, Polazzi E, Ade P, Balduzzi M, and Levi G. Prostaglandin E2 synthesis is differentially affected by reactive nitrogen intermediates in cultured rat microglia and RAW 264.7 cells. FEBS Lett 413: 314-318, 1997.
34. Gudi T, Huvar I, Meinecke M, Lohmann SM, Boss GR, and Pilz RB. Regulation of gene expression by cGMP-dependent protein kinase. J Biol Chem 271: 4597-4600, 1996.
35. Gudi T, Lohmann SM, and Pilz RB. Regulation of gene expression by cyclic GMP-dependent protein kinase requires nuclear translocation of the kinase: identification of a nuclear localization signal. Mol Cell Biol 17: 5244-5254, 1997.
36. Gudi T, Hong GK, Vaandrager AB, Lohmann SM, and Pilz RB. Nitric oxide and cGMP regulate gene expression in neuronal and glial cells by activating type II cGMP-dependent protein kinase. FASEB J 13: 2143-2152, 1999.
37. Habib A, Bernard C, Lebret M, Créminon C, Esposito B, Tedgui A, and Maclouf J. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol 158: 3845-3851, 1997.
38. Harris RC, Cheng H, Wang J, Zhang M, and McKanna JA. Interactions of the renin-angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase-2 in the macula densa. Acta Physiol Scand 168: 47-51, 2000.
39. Hattori M-A, Sakamoto K, Fujihara N, and Kojima I. Nitric oxide: a modulator for the epidermal growth factor receptor expression in developing ovarian granulosa cells. Am J Physiol 270: C812-C818, 1996.
40. Henrion D, Dechaux E, Dowell FJ, Maclour J, Samuel JL, Levy BI, and Michel JB. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. Br J Pharmacol 121: 83-90, 1997.
41. Hentze, MW, and Kühn, LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A 93: 8175-8182, 1996.
42. Hirai K, Ezumi Y, Nishida E, Uchiyama T, and Takayama H. Comparative study of vanadate-and phorbol ester-induced cyclo-oxygenase-2 expression in human endothelial cells. Thromb Haemost 82: 1545-1552, 1999.
43. Hmadcha A, Bedoya FJ, Sobrino F, and Pintado E. Methylation-dependent gene silencing induced by interleukin 1β via nitric oxide production. J Exp Med 190: 1595-1604, 1999.
44. Honda S, Migita K, Hirai Y, Ueki Y, Yamasaki S, Urayama S, Kawabe Y, Fukuda T, Kawakami A, Kamachi M, Kita M, Ida H, Aoyagi T, and Eguchi K. Induction of COX-2 expression by nitric oxide in rheumatoid synovial cells. Biochem Biophys Res Commun 268: 928-931, 2000.
45. Hughes FJ, Buttery LD, Hukkanen MV, O'Donnell A, Maclouf J, and Polak JM. Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro. J Biol Chem 274: 1776-1782, 1999.
46. Ikeda M, Ikeda U, Takahashi M, Shimada K, Minota S, and Kano S. Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells. J Am Soc Nephrol 7: 2213-2218, 1996.
47. Iñiguez MA, Martinez-Martinez S, Punzon C, Redondo JM, and Fresno M. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Biol Chem 275: 23627-23635, 2000.
48. Inoue H, Yokoyama C, Hara S, Tone Y, and Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. J Biol Chem 270: 24965-24971, 1995.
49. Inoue H, Tanabe T, and Umesono K. Feedback control of cyclooxygenase-2 expression through PPARγ. J Biol Chem 275: 28028-28032, 2000.
50. Ip YT, and Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10: 205-219, 1998.
51. Janssen-Heininger YM, Poynter ME, and Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor KB. Free Radic Biol Med 28: 1317-1327, 2000.
52. Janssen-Heininger YMW, Macara I, and Mossman BT. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-κB. Am J Respir Cell Mol Biol 20: 942-952, 1999.
53. Katsuyama K, Shichiri M, Marumo F, and Hirata Y. NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α. Arterioscler Thromb Vasc Biol 18: 1796-1802, 1998.
54. Kiemer AK, and Vollmar AM. Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J Biol Chem 273: 13444-13451, 1998.
55. Kim H, Shim J, Han PL, and Choi-EJ. Nitric oxide modulates the c-Jun N-terminal kinase/stress-activated protein kinase activity through activating c-Jun N-terminal kinase kinase. Biochemistry 36: 13677-13681, 1997.
56. Kim Y, and Fischer SM. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J Biol Chem 273: 27686-27694, 1998.
57. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, and Esumi H. Hypoxia response element of human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95: 187-197, 2000.
58. Kirtikara K, Raghow R, Laulederkind SJ, Goorha S, Kanekura T, and Ballou LR. Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements. Mol Cell Biochem 203: 41-51, 2000.
59. Klatt P, and Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 267: 4928-4944, 2000.
60. Klatt P, Molina EP, and Lamas S. Nitric oxide inhibits c-jun DNA binding by specifically targeted S-glutathionylation. J Biol Chem: 15857-15864, 1999.
61. Klatt P, Molina EP, Pérez-Sala D, and Lamas S. Novel application of S-nitrosoglutathione Sepharose to identify proteins that are potential targets for S-nitrosoglutathione-induced mixed disulfide formation. Biochem J 349: 567-578, 2000.
62. Komalavilas P, Shah PK, Jo H, and Lincoln TM. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J Biol Chem 274: 34301-34309, 1999.
63. Lamas S, and Michel T. Molecular biological features of nitric oxide synthase isoforms. In: Nitric Oxide and the Lung, edited by Zapol WM, and Bloch KD. New York, NY: Marcel Dekker, 1997, pp. 59-73.
64. ras interaction. J Biol Chem 272: 4323-4326, 1997.
65. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluchkman KD, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 483-492, 1995.
66. LaPointe MC, and Isenovic E. Interleukin-1β regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension 33: 276-282, 1999.
67. Ledingham MA, Denison FC, Kelly RW, Young A, and Norman JE. Nitric oxide donors stimulate prostaglandin F(2α) and inhibit thromboxane B(2) production in the human cervix during the first trimester of pregnancy. Mol Hum Reprod 5: 973-982, 1999.
68. Levi G, Minghetti L, and Aloisi F. Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie 80: 899-904, 1998.
69. Li M, Pascual G, and Glass CK. Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol 20: 4699-4707, 2000.
70. Lianos EA, Guglielmi K, and Sharma M. Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury. Kidney Int. 53: 645-653, 1998.
71. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, and De Jonge HR. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci 22: 307-312, 1997.
72. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 268: 12231-12234, 1993.
73. Marnett LJ, Wright TL, Crews BC, Tannenbaum SR, and Morrow JD. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J Biol Chem 275: 13427-13430, 2000.
74. Marotta P, Sautebin L, and Di Rosa M. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 107: 640-641, 1992.
75. Matthews JR, Botting CH, Panico M, Morris HR, and Hay RT. Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res 24: 2236-2242, 1996.
76. Meade EA, McIntyre TM, Zimmerman GA, and Prescott SM. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 274: 8328-8334, 1999.
77. Milano S, Arcoleo F, Dieli M, D'Agostino R, D'Agostino P, De Nucci G, and Cillari E. Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 49: 105-115, 1995.
78. Miller BW, Baier LD, and Morrison AR. Overexpression of protein kinase C-ζ isoform increases cyclooxygenase-2 and inducible nitric oxide synthase. Am J Physiol 273: C130-C136, 1997.
79. Miller C, Zhang M, He Y, Zhao J, Pelletier JP, Martel-Pelletier J, and Di Battista JA. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J Cell Biochem 69: 392-413, 1998.
80. Minghetti L, Polazzi E, Nicolini A, Creminon C, and Levi G. Interferon-γ and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J Neurochem 66: 1963-1970, 1996.
81. Molina-Holgado E, Ortiz S, Molina-Holgado F, and Guaza C. Induction of COX-2 and PGE(2) biosynthesis by IL-1beta is mediated by PKC and mitogenactivated protein kinases in murine astrocytes. Br J Pharmacol 131: 152-159, 2000.
82. Moncada S, and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
83. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, and Smithies O. Prostaglandin synthase-2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473-482, 1995.
84. Mühl H, and Pfeilschifter J. Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1β-stimulated rat mesangial cells. J Clin Invest 95: 1941-1946, 1995.
85. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997.
86. Newton R, Kuitert LM, Bergmann M, Adcock IM, and Barnes PJ. Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β. Biochem Biophys Res Commun 237: 28-32, 1997.
87. Nitikovic D, Holmgren A, and Spyrou G. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochem Biophys Res Commun 242: 109-112, 1998.
88. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, and Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci U S A 95: 10966-10971, 1998.
89. Nusing RM, Klein T, Pfeilschifter J, and Ullrich V. Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide-and prostanoid-forming pathways in cultured rat mesangial cells. Biochem J 313: 617-623, 1996.
90. Pang L, and Hoult JR. Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages. Biochem Pharmacol 53: 493-500, 1997.
91. Pantopoulos K, and Hentze MW. Nitric oxide signaling to iron-regulatory protein: direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts. Proc Natl Acad Sci U S A 92: 1267-1271, 1995.
92. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, and Ziche M. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 273: 4220-4226, 1998.
93. Park SK, Lin HL, and Murphy S. Nitric oxide limits transcriptional induction of nitric oxide synthase in CNS glial cells. Biochem Biophys Res Commun 201: 762-768, 1994.
94. Park SK, Lin HL, and Murphy S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA. Biochem J 322: 609-613, 1997.
95. Patel R, Attur MG, Dave M, Abramson SB, and Amin AR. Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages. J Immunol 162: 4191-4197, 1999.
96. Paul A, Cuenda A, Bryant CE, Murray J, Chilvers ER, Cohen P, Gould G W, and Plevin R. Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages. Cell Signal 11: 491-497, 1999.
97. Pelletier JP, Lascau-Coman V, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, and Martel-Pelletier J. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 26: 2002-2014, 1999.
98. Peng H-B, Libby P, and Liao JK. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J Biol Chem 270: 14214-14219, 1995.
99. Pérez-Sala D, Díaz-Cazorla M, Ros J, Jiménez W, and Lamas S. Tetrahydrobiopterin modulates cyclooxygenase-2 expression in human mesangial cells. Biochem Biophys Res Commun 241: 7-12, 1997.
100. Perkins DJ, and Kniss DA. Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages. J Leukoc Biol 65: 792-799, 1999.
101. Peunova N, and Enikolopov G. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature 364: 450-453, 1993.
102. Pfeifer A, Ruth P, Dostmann W, Sausbier M, Klatt P, and Hofmann F. Structure and function of cGMP-dependent protein kinases. Rev Physiol Biochem Pharmacol 135: 105-149, 1999.
103. Pilz RB, Suhasini M, Idriss S, Meinkoth JL, and Boss GR. Nitric oxide and cGMP analogs activate transcription from AP-1 responsive promoters in mammalian cells. FASEB J 9: 552-558, 1995.
104. Posadas I, Terencio MC, Guillen I, Ferrandiz ML, Coloma J, Paya M, and Alcaraz MJ. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Naunyn Schmiedebergs Arch Pharmacol 361: 98-106, 2000.
105. Prescott SM, and Fitzpatrick FA. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 1470: M69-M78, 2000.
106. Rzymkiewicz DM, DuMaine J, and Morrison AR. IL-1β regulates rat mesangial cyclooxygenase II gene expression by tyrosine phosphorylation. Kidney Int 47: 1354-1363, 1995.
107. Salvemini D, and Masferrer JL. Interactions of nitric oxide with cyclooxygenase: in vitro, ex vivo, and in vivo studies. Methods Enzymol 269: 12-25, 1996.
108. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 90: 7240-7244, 1993.
109. Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG, and Needleman P. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 114: 1171-1178, 1995.
110. Schmedtje JF Jr., Ji YS, Liu WL, DuBois RN, and Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272: 601-608, 1997.
111. Schonbeck U, Sukhova GK, Graber P, Coulter S, and Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 155: 1281-1291, 1999.
112. Schuette R, and LaPointe MC. Phorbol ester stimulates cyclooxygenase-2 expression and prostanoid production in cardiac myocytes. Am J Physiol 279: H719-H725, 2000.
113. Shirakawa F, and Mizel S. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol 9: 2424-2430, 1989.
114. Smith W, Garavito R, and DeWitt D. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157-33160, 1996.
115. Soff GA, Cornwell TL, Cundiff DL, Gately S, and Lincoln TM. Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J Clin Invest 100: 2580-2587, 1997.
116. Spiecker M, Peng HB, and Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκBα. J Biol Chem 272: 30969-30974, 1997.
117. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936, 1994.
118. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, and Glass CK. 15-Deoxy-Δ-12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci U S A 97: 4844-4849, 2000.
119. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1411: 217-230, 1999.
120. Swaisgood CM, Zu HX, Perkins DJ, Wu S, Garver CL, Zimmerman PD, lams JD, and Kniss DA. Coordinate expression of inducible nitric oxide synthase and cyclooxygenase-2 genes in uterine tissues of endotoxin-treated pregnant mice. Am J Obstet Gynecol 177: 1253-1262, 1997.
121. Swierkosz TA, Mitchell JA, Tomlinson A, Botting RM, Warner TD, and Vane JR. Relationship between different isoforms of nitric oxide synthase and cyclooxygenase in various cell types. Pol J Pharmacol 46: 587-592, 1994.
122. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci U S A 91: 12168-12172, 1994.
123. Tetsuka T, Daphna-Iken D, Miller BW, Guan Z, Baier LD, and Morrison AR. Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J Clin Invest 97: 2051-2056, 1996.
124. Tomlinson A, Appleton I, Moore AR, Gilroy DW, Willis D, Mitchell JA, and Willoughby DA. Cyclooxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol 113: 693-698, 1994.
125. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232-235, 1971.
126. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, and Willoughby DA. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A 91: 2046-2050, 1994.
127. Vodovotz Y, Chesler L, Chong H, Kim S-J, Simpson JT, DeGraff W, Cox GW, Roberts AB, Wink DA, and Barcellos-Hoff MH. Regulation of transforming growth factor β1 by nitric oxide. Cancer Res 59: 2142-2149, 1999.
128. von Knethen A, and Brune B. Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis. FASEB J 11: 887-895, 1997.
129. von Knethen A, and Brüne B. Superinduction of cyclooxygenase-2 by NO(*) and agonist challenge involves transcriptional regulation mediated by AP-1 activation. Biochemistry 39: 1532-1540, 2000.
130. Wallace JL. Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs). Am J Med 107: 11S-17S, 1999.
131. Wang S, Yan L, Wesley RA, and Danner RL. Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP. J Biol Chem 272: 5959-5965, 1997.
132. Williams CS, Mann M, and DuBois RN. The role of cyclooxygenases in inflammation, cancer and development. Oncogene 18: 7908-7916, 1999.
133. Wu KK. Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol 33: 179-207, 1995.
134. Xie W, Chipman JG, Robertson DL, Erikson RL, and Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A 88: 2692-2696, 1991.
135. Xu Q. Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1. J Clin Invest 100: 1089-1097, 1997.
136. Xu Q, Ji YS, and Schmedtje JF Jr. Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure. J Biol Chem 275: 24583-24589, 2000.
137. Yamamoto K, Arakawa T, Ueda N, and Yamamoto S. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270: 31315-31320, 1995.
138. Yang T, Huang Y, Heasley LE, Berl T, Schnermann JB, and Briggs JP. MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells. J Biol Chem 275: 23281-23286, 2000.
139. Zeiher AM, Fisslthaler B, Schray-Utz B, and Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76: 980-986, 1995.
140. Zhang J, Velsor LW, Patel JM, Postlethwait EM, and Block ER. Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NF-κB. Am J Physiol 277: L787-L793, 1999.
141. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, and Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424, 1997.